Relative efficacy of varicella vaccines: network meta-analysis of randomized controlled trials

References

• Schmidt-Chanasit J, Sauerbrei A. Evolution and world-wide distribution of varicella–zoster virus clades. Infect Genet Evol. 2011;11(1):1–10.
   PubMed Web of Science ®Google Scholar
• Heininger U, Seward JF. Varicella. Lancet. 2006;368(9544):1365–1376.
   PubMed Web of Science ®Google Scholar
• Mueller NH, Gilden DH, Cohrs RJ, et al. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin. 2008;26(3):675–697.
   PubMed Web of Science ®Google Scholar
• Gershon AA, Breuer J, Cohen JI, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1:15016.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiolo Rec. 2014;89(25):265–287.
   PubMedGoogle Scholar
• Wutzler P, Bonanni P, Burgess M, et al. Varicella vaccination – the global experience. Expert Rev Vaccines. 2017;16(8):833–843.
   PubMed Web of Science ®Google Scholar
• Zhou F, Harpaz R, Jumaan AO, et al. Impact of varicella vaccination on health care utilization. Jama. 2005;294(7):797–802.
   PubMed Web of Science ®Google Scholar
• Tan B, Bettinger J, McConnell A, et al. The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT Centers, Canada, 2000–2008. Pediat Infect Dis J. 2012;31(9):956–963.
   PubMed Web of Science ®Google Scholar
• Marin M, Zhang JX, Seward JF. Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics. 2011;128(2):214–220.
   PubMed Web of Science ®Google Scholar
• Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2019;15(3):645–657.
   PubMed Web of Science ®Google Scholar
• Kuter B, Matthews H, Shinefield H, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediat Infect Dis J. 2004;23(2):132–137.
   PubMed Web of Science ®Google Scholar
• Povey M, Henry O, Bergsaker MAR, et al. Protection against varicella with two doses of combined measles–mumps–rubella–varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial. Lancet Infect Dis. 2019;19(3):287–297.
   PubMed Web of Science ®Google Scholar
• Marin M, Marti M, Kambhampati A, et al. Global varicella vaccine effectiveness: a meta-analysis. Pediatrics. 2016;137(3):e20153741.
   PubMed Web of Science ®Google Scholar
• Mitra M. Systematic review of effectiveness of varicella vaccines: a critical appraisal: immunization experts viewpoint. Indian Pediatr. 2016;53(5):420–422.
   PubMed Web of Science ®Google Scholar
• Hoaglin DC, Hawkins N, Jansen JP, et al. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on indirect treatment comparisons good research practices: part 2. Value Health. 2011;14(4):429–437.
   PubMed Web of Science ®Google Scholar
• Jansen JP, Fleurence R, Devine B, et al. Interpreting indirect treatment comparisons and network Meta-analysis for health-care decision making: report of the ISPOR Task Force on indirect treatment comparisons good research practices: part 1. Value Health. 2011;14(4):417–428.
   PubMed Web of Science ®Google Scholar
• Dias S, Caldwell DM. Network meta-analysis explained. Arch Dis Child Fetal Neonatal Ed. 2019;104(1):F8–F12.
   PubMed Web of Science ®Google Scholar
• Rouse B, Chaimani A, Li T. Network meta-analysis: an introduction for clinicians. Intern Emerg Med. 2017;12(1):103–111.
   PubMed Web of Science ®Google Scholar
• McGirr A, Widenmaier R, Curran D, et al. The comparative efficacy and safety of herpes zoster vaccines: a network meta-analysis. Vaccine. 2019;37(22):2896–2909.
   PubMed Web of Science ®Google Scholar
• Tricco AC, Zarin W, Cardoso R, et al. Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis. BMJ. 2018;363:k4029.
   PubMed Web of Science ®Google Scholar
• Zhang W, Sun H, Atiquzzaman M, et al. Influenza vaccination for HIV-positive people: systematic review and network meta-analysis. Vaccine. 2018;36(28):4077–4086.
   PubMed Web of Science ®Google Scholar
• Rogliani P, Chetta A, Cazzola M, et al. SARS-CoV-2 neutralizing antibodies: a network meta-analysis across vaccines. Vaccines. 2021;9(3):227.
   Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLOS Med. 2009;6(7):e1000100.
   PubMed Web of Science ®Google Scholar
• Centre for Reviews and Dissemination. Systematic reviews. CRD’s guidance for undertaking reviews in health care [Internet] [cited 2020 Nov 2]. Available from: https://www.york.ac.uk/media/crd/Systematic_Reviews.pdf
   Google Scholar
• Higgins JGS. Cochrane handbook for systematic reviews of interventions. The Cochrane collaboration. 5.1.10. 2011 [Internet] [cited 2020 Oct 2]. Available from: https://handbook-5-1.cochrane.org/
   Google Scholar
• Dias S, Sutton AJ, Ades AE, et al. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making. 2013;33(5):607–617.
   PubMed Web of Science ®Google Scholar
• Rhodes KM, Turner RM, Higgins JP. Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data. J Clin Epidemiol. 2015;68(1):52–60.
   PubMed Web of Science ®Google Scholar
• Pedder H, Boucher M, Dias S, et al. Performance of model-based network meta-analysis (MBNMA) of time-course relationships: a simulation study. Res Synth Methods. 2020;11(5):678–697.
   PubMed Web of Science ®Google Scholar
• Mbuagbaw L, Rochwerg B, Jaeschke R, et al. Approaches to interpreting and choosing the best treatments in network meta-analyses. Syst Rev. 2017;6(1):79.
   PubMed Web of Science ®Google Scholar
• Hao B, Chen Z, Zeng G, et al. Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial. Clin Microbiol Infect. 2019;25(8):1026–1031.
   PubMed Web of Science ®Google Scholar
• Knuf M, Zepp F, Helm K, et al. Antibody persistence for 3 years following two doses of tetravalent measles–mumps–rubella–varicella vaccine in healthy children. Eur J Pediatr. 2012;171(3):463–470.
   PubMed Web of Science ®Google Scholar
• Kuter BJ, Weibel RE, Guess HA, et al. Oka/merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine. 1991;9(9):643–647.
   PubMed Web of Science ®Google Scholar
• Prymula R, Bergsaker MR, Esposito S, et al. Protection against varicella with two doses of combined measles–mumps–rubella–varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial. Lancet. 2014;383(9925):1313–1324.
   PubMed Web of Science ®Google Scholar
• Shinefield HR, Black SB, Staehle BO; Kaiser Permanente Medical Team for Varivax, et al. Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children. Pediatr Infect Dis J. 2002;21(6):555–561.
   PubMed Web of Science ®Google Scholar
• Varis T, Vesikari T. Efficacy of high-titer live attenuated varicella vaccine in healthy young children. J Infect Dis. 1996;174(Suppl 3):S330–S334.
   PubMed Web of Science ®Google Scholar
• White CJ, Stinson D, Staehle B, et al. Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, mumps, rubella, varicella vaccine study group. Clin Infect Dis. 1997;24(5):925–931.
   PubMed Web of Science ®Google Scholar
• Casabona G, Habib MA, Povey M, et al. Randomised controlled trial showed long-term efficacy, immunogenicity and safety of varicella vaccines in Norwegian and Swedish children. Acta Paediatr. 2022;111(2):391–400.
   PubMed Web of Science ®Google Scholar
• Czajka H, Brzostek J, Gabutti G, et al. Comparison of six year efficacy between one or two doses of live varicella virus-containing vaccines: a randomized, placebo-controlled trial. European Society for Paediatric Infectious Diseases – 33rd Annual Meeting; 2015 May 12–16; Leipzig, Germany; 2015. p. ESPID-0644.
   Google Scholar
• Henry O, Brzostek J, Czajka H, et al. One or two doses of live varicella virus-containing vaccines: efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life. Vaccine. 2018;36(3):381–387.
   PubMed Web of Science ®Google Scholar
• Klein NP, Fireman B, Enright A, et al. A role for genetics in the immune response to the varicella vaccine. Pediat Infect Dis J. 2007;26(4):300–305.
   PubMed Web of Science ®Google Scholar
• Namazova-Baranova L, Habib MA, Povey M, et al. A randomized trial assessing the efficacy, immunogenicity, and safety of vaccination with live attenuated varicella zoster virus-containing vaccines: ten-year follow-up in Russian children. Hum Vaccin Immunother. 2021 Aug 26:1–12.
   Web of Science ®Google Scholar
• Ngai AL, Staehle BO, Kuter BJ, et al. Safety and immunogenicity of one vs. two injections of oka/merck varicella vaccine in healthy children. Pediat Infect Dis J. 1996;15(1):49–54.
   PubMed Web of Science ®Google Scholar
• Prymula R, Povey M, Brzostek J, et al. Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles–mumps–rubella–varicella vaccine or one dose of monovalent varicella vaccine: results from five east European countries. Vaccine. 2021;39(19):2643–2651.
   PubMed Web of Science ®Google Scholar
• Watson BM, Piercy SA, Plotkin SA, et al. Modified chickenpox in children immunized with the oka/merck varicella vaccine. Pediatrics. 1993;91(1):17–22.
   PubMed Web of Science ®Google Scholar
• Weibel RE, Neff BJ, Kuter BJ, et al. Live attenuated varicella virus vaccine. Efficacy trial in healthy children. N Engl J Med. 1984;310(22):1409–1415.
   PubMed Web of Science ®Google Scholar
• Latasa P, Gil de Miguel A, Barranco Ordoñez MD, et al. Effectiveness and impact of a single-dose vaccine against chickenpox in the community of Madrid between 2001 and 2015. Hum Vaccin Immunother. 2018;14(9):2274–2280.
   PubMed Web of Science ®Google Scholar
• Yin M, Xu X, Liang Y, et al. Effectiveness, immunogenicity and safety of one vs. two-dose varicella vaccination: a meta-analysis. Expert Rev Vaccines. 2018;17(4):351–362.
   PubMed Web of Science ®Google Scholar
• Spackova M, Wiese-Posselt M, Dehnert M, et al. Comparative varicella vaccine effectiveness during outbreaks in day-care centres. Vaccine. 2010;28(3):686–691.
   PubMed Web of Science ®Google Scholar
• Pillsbury M, Carias C, Samant S, et al. Comparison of performance of varicella vaccines via infectious disease modeling. Vaccine. 2022;40(29):3954–3962.
   PubMed Web of Science ®Google Scholar